Exhibit Hall Theater
.png)
NUVISAN Innovation Campus Berlin (ICB) GmbH is an Australian-owned, European-based CRO and your go-to partner for all your therapeutic development needs. Our expertise and capabilities span the entire pharmaceutical discovery pipeline from target identification and validation through to phase 3 clinical trials. Experts from our four main functions serve your project to streamline drug development. With flexible entry points, we thrive by working collaboratively with you to achieve both scientific rigour and yield the best possible outcome.
In our presentation, we will give you a brief introduction to the company, an overview of our extensive capabilities (including our unique access to compound libraries not available elsewhere) and examples of how we can work with you to leverage human iPSCs in your drug discovery journey. We also look forward to meeting and sharing more details with you at our booth.